AB 2690

10 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.

Start with

and connect to

Every link on this map

The same connections as a table, with the reason each one is here.

Sort by

Connections of AB 2690

Paul Krekorian	Sponsors	Paul Krekorian sponsored AB 2690.	None
Amylin Pharmaceuticals, Inc.	Lobbied on it	Amylin Pharmaceuticals, Inc. named AB 2690 in 4 lobbying reports.	4 reports
Astrazeneca Pharmaceuticals, LP	Lobbied on it	Astrazeneca Pharmaceuticals, LP named AB 2690 in 4 lobbying reports.	4 reports
Boehringer Ingelheim Pharmaceuticals, Inc.	Lobbied on it	Boehringer Ingelheim Pharmaceuticals, Inc. named AB 2690 in 4 lobbying reports.	4 reports
Procter & Gamble	Lobbied on it	Procter & Gamble named AB 2690 in 4 lobbying reports.	4 reports
Purdue Pharma L.P.	Lobbied on it	Purdue Pharma L.P. named AB 2690 in 4 lobbying reports.	4 reports
Takeda Pharmaceuticals America	Lobbied on it	Takeda Pharmaceuticals America named AB 2690 in 4 lobbying reports.	4 reports
Talecris Biotherapeutics, Inc., A Wholly Owned Subsidiary of Grifols Inc.	Lobbied on it	Talecris Biotherapeutics, Inc., A Wholly Owned Subsidiary of Grifols Inc. named AB 2690 in 4 lobbying reports.	4 reports
Edwards Lifesciences	Lobbied on it	Edwards Lifesciences named AB 2690 in 3 lobbying reports.	3 reports
Product liability actions: prescription pharmaceutical products.	Source records	AB 2690 has an explicit source reference to Product liability actions: prescription pharmaceutical products..	None

Reporting about the selected subject. Articles are context and do not establish a connection on this map.

Loading coverage…